Publicacións nas que colabora con Olalla Maroñas Amigo (8)
2024
-
Role of CYP2D6 and CYP3A4 polymorphisms on aripiprazole and dehydroaripiprazole concentrations in patients undergoing long-acting treatment
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 135
-
Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling
Psychiatry Research, Vol. 333
2023
-
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration
Investigative ophthalmology & visual science, Vol. 64, Núm. 13, pp. 34
2021
-
Review of pharmacokinetics and pharmacogenetics in atypical long-acting injectable antipsychotics
Pharmaceutics, Vol. 13, Núm. 7
2020
-
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations
British Journal of Clinical Pharmacology, Vol. 86, Núm. 8, pp. 1661-1666
-
Anti-VEGF treatment and response in age-related macular degeneration: Disease’s susceptibility, pharmacogenetics and pharmacokinetics
Current Medicinal Chemistry, Vol. 27, Núm. 4, pp. 549-569
-
Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic-Pharmacokinetic Prospective Multicenter Study
Pharmacotherapy, Vol. 40, Núm. 1, pp. 17-25
2019
-
Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration
Pharmaceutics, Vol. 11, Núm. 8